Related Experiment Videos
Interventions to improve adherence to lipid lowering medication.
A Schedlbauer1, K Schroeder, T J Peters
1Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol, Cotham House, Cotham Hill, Bristol, UK, BS6 6JL. A.Schedlbauer@bristol.ac.uk
The Cochrane Database of Systematic Reviews
|October 21, 2004
Summary
Improving adherence to lipid-lowering drugs is crucial for cardiovascular health. While various interventions show promise, no single method is superior, and research quality needs improvement.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Lipid-lowering drugs are underutilized for cardiovascular disease prevention.
- Poor patient adherence significantly hinders hyperlipidemia treatment success.
- Interventions to improve adherence are vital for patients at risk of heart disease or stroke.
Purpose of the Study:
- To evaluate the effectiveness of interventions designed to enhance adherence to lipid-lowering medications.
- To assess the impact of these interventions on adherence rates and clinical outcomes.
Main Methods:
- Systematic review of randomized controlled trials (RCTs) identified through comprehensive database searches (CENTRAL, MEDLINE, EMBASE, PsycInfo, CINAHL) up to February 2003.
- Included adults in ambulatory settings for primary and secondary cardiovascular disease prevention.
- Data extraction and quality assessment performed independently by two reviewers.
Main Results:
- Eight RCTs involving 5943 patients were analyzed.
- Interventions included regimen simplification, patient education, intensified care (e.g., reminders), and behavioral interventions.
- Adherence improvements ranged from -3% to 25%, with significant gains noted in regimen simplification, education, and reminding strategies.
- No single intervention type demonstrated a clear advantage.
Conclusions:
- Currently, no specific intervention can be definitively recommended for improving adherence to lipid-lowering drugs.
- Challenges include the lack of a gold standard for adherence measurement and heterogeneity among studies.
- Future research requires more consistent adherence assessment, longer follow-up, and a greater focus on patient-centered approaches like shared decision-making.